Inmarsat Takes Another Leap Forward With ELERA, The Global Network for IoT, Safety and Mission Critical Connectivity
12.8.2021 13:12:00 EEST | Business Wire | Press release
In its second major announcement in two weeks, Inmarsat is today unveiling Inmarsat ELERA; a global narrowband network that is ideally suited to the rapidly evolving world of the Internet of Things (IoT) and for global mobility customers, including aviation, maritime, governments and select enterprises.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210812005417/en/
Inmarsat Takes Another Leap Forward With ELERA, The Global Network for IoT, Safety and Mission Critical Connectivity (Photo: Business Wire)
“ELERA is perfectly suited to the needs of the connected IoT world,” said Rajeev Suri, CEO, Inmarsat. “Global reach, extraordinary resilience, faster speeds, smaller and lower cost terminals are all part of ensuring that we remain ahead of others in meeting the needs of our customers.”
“ELERA is a further sign of a company with true momentum and one that is delivering new innovations and strong performance,” continued Suri. “I expect that Inmarsat will grow strongly in 2021 compared to the previous year, and that growth will span most of our business units. Our progress was evident in the first half, where we saw strong growth in revenue and EBITDA and robust cash flow. We have sharpened our strategy to focus on driving growth, accelerate decision making, launch new innovations, and are creating a more commercially focused, customer-centric culture.”
ELERA builds on Inmarsat’s #1 position in Mobile Satellite Services (MSS) and will be a springboard for innovation, unlocking, accelerating and scaling pioneering use cases on land, at sea and in the air. Its foundation is Inmarsat’s world class L-band network and incorporates new innovations ranging from higher speeds to smaller, low cost terminals and [the previously announced] Inmarsat-6 satellites, the first of which (I-6 F1) is scheduled to launch before the end of the year.
Coming just 14 days after Inmarsat announced ORCHESTRA, the world’s first network to combine GEO, LEO and 5G into one harmonious global communications solution, ELERA underlines Inmarsat’s strategic focus on the global mobility segment of satellite communications. It is also a signal of a company with momentum, delivering major technological innovations and growth.
The unique capabilities of ELERA, combined with Inmarsat’s superior spectrum and the ideally suited orbital position of its satellite networks, will make it the essential catalyst for new IoT use cases, across everything from autonomous transport and unmanned aerial vehicles (UAV) to industrial and agricultural IoT applications.
ELERA Innovation
ELERA is built on Inmarsat’s market leading L-band network, which already delivers the world’s most reliable and flexible global connectivity service with unique resilience in all conditions and full global redundancy. It supports everything from worldwide maritime and aviation safety services and humanitarian missions to IoT applications across agritech, transportation and utilities, among many others.
The new innovations that the company is investing in to bring to market in the near future include spectrum management technology to deliver L-band speeds up to 1.7Mbps, the smallest footprint, low cost L-band terminal and two new L-band satellites, which are the largest and most sophisticated commercial communication satellites ever created.
The new spectrum management capabilities (known as Carrier Aggregation) being incorporated into the ELERA network will deliver the fastest speeds globally available to L-band customers, far outstripping the capabilities of any other worldwide L-band network.
Live customer trials in commercial aviation are scheduled to start during the course of 2022 and this technology will be rolled out across a range of sector specific applications for Inmarsat’s mobility, government and IoT customers over the coming few years.
ELERA will also see the creation of the smallest footprint, low cost terminal for L-band users, delivering the ideal framework for satcom IoT at scale, with supporting cloud-based management, for vertical sectors such as infrastructure, rail, logistics, mining, agriculture, government, maritime and aviation.
Inmarsat is launching two new satellites to enhance the ELERA network. The I-6 satellites, the first of which is scheduled to launch at the end of 2021, are the largest and most sophisticated commercial communications satellites ever built.
The L-band capacity on each I-6 satellite will be substantially greater than Inmarsat’s 4th generation spacecraft and, among other enhancements, they will deliver 50% more capacity per beam; meaning that much more data can be carried over the same geographical area, in addition to unlimited beam routing flexibility.
ELERA will also deliver a major extension to Inmarsat’s portfolio of voice-enabled devices, bringing new capabilities and innovations to hundreds of thousands of customers. This initiative represents our commitment to voice service innovation and underlines the company’s long-term commitment to the handheld voice services over satellite market.
“ELERA is the exciting vision of how Inmarsat is planning to transform the capabilities offered to IoT and mobility customers for years to come and confirms our long-term commitment to L-band services. We will be sharing further detail on these innovations with our partner community in the coming months and continue our programme of announcements as we achieve major milestones.” said Rajeev Suri, CEO, Inmarsat.
The investments in ELERA are already included in Inmarsat’s current CAPEX plans and guidance.
ENDS
Notes to Editors
ABOUT INMARSAT
Inmarsat is the world leader in global, mobile satellite communications. It owns and operates the world’s most diverse global portfolio of mobile telecommunications satellite networks, and holds a multi-layered, global spectrum portfolio, covering L-band, Ka-band and S-band, enabling unparalleled breadth and diversity in the solutions it provides. Inmarsat’s long-established global distribution network includes not only the world’s leading channel partners but also its own strong direct retail capabilities, enabling end to end customer service assurance.
The company has an unrivalled track record of operating the world’s most reliable global mobile satellite telecommunications networks, sustaining business and mission critical safety and operational applications for more than 40 years. It is also a major driving force behind technological innovation in mobile satellite communications, sustaining its leadership through a substantial investment and a powerful network of technology and manufacturing partners.
Inmarsat operates across a diversified portfolio of sectors with the financial resources to fund its business strategy and holds leading positions in the Maritime, Government, Aviation and Enterprise satcoms markets, operating consistently as a trusted, responsive and high-quality partner to its customers across the globe.
For further information, follow us: Twitter | LinkedIn | Facebook | YouTube | Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210812005417/en/
Contact information
Media enquiries:
Jonathan Sinnatt / Matthew Knowles
Corporate Communications
Tel: +44 (0)788 960 5272 / +44 (0) 7725 476 507
press@inmarsat.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging
TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 10:00:00 EEST | Press release
Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803353435/en/ Adtran’s SDX 6400 Series is helping TOHKnet demonstrate how Japan’s operators can migrate to 50G PON without disrupting existing PON services. “As demand for digital services continues to grow, this trial is a key milestone for the future of fiber access in Jap
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 10:00:00 EEST | Press release
The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the project continues to captivate audiences through its
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer4.8.2026 10:00:00 EEST | Press release
Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-mutated advanced / metastatic breast cancer. Rupitasertib, is a first-in-class oral dual-node PI3K/AKT/mTOR (PAM) pathway inhibitor, which selectively inhibits S6K and AKT1/3. Rupitasertib was purposefully and rationally designed to target S6K for potent PAM inhibition and AKT1/3 to block the AKT compensatory feedback loop, while sparing AKT2 to avoid hyperglycemia, which we believe will lead to a superior efficacy and safety profile compared to other PAM pathway inhibitors. Under the terms of the agreement, Roche will s
Bending Spoons has entered into a definitive agreement to acquire Airtable for $1.285 billion4.8.2026 09:30:00 EEST | Press release
Bending Spoons S.p.A. (NASDAQ: BSP) announced that it has entered into a definitive agreement to acquire Airtable, in an all-cash transaction that values Airtable at an enterprise value of $1.285 billion, which, together with Airtable’s current net cash-and-cash-equivalents balance, implies an equity value of approximately $2.25 billion. The acquisition is subject to customary closing conditions and approvals, including regulatory approvals. “We’re looking forward to welcoming Airtable into Bending Spoons,” said Luca Ferrari, Bending Spoons CEO and co-founder. “Airtable is a pioneering brand reshaping how teams organize data and manage critical workflows. The value being delivered is reflected in annual recurring revenue growing over 20% YoY to approximately $480 million as of June 2026, and joining forces with Bending Spoons will accelerate innovation even further. We’re committed to investing in Airtable for the long run, and doubling down on its core strength: bringing teams and wor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
